Tsvagurudzo yegenetic inogadzirisa makumi matatu emakore erukemia chakavanzika

Share This Post

Vatsvagiri paUniversity yeCalifornia, San Francisco uye St. Jude Vana Chipatara Chekutsvagisa muTennessee vakagadzirisa zvakavanzika zvekurapa makumi emakore apfuura, uye vakawana paine majini ekuchinja anogona kukonzeresa zvirwere zvemhuri neropa uye kunyange leukemia. Chidzidzo ichi chakanangana nekuongororwa kweDNA kwevakoma nevanun'una gumi nevatanhatu mumhuri shanu, zvichiratidza kuti vamwe vana vane majenasi vachazvigadzirira vega, uye vakawanawo mamwe mamaki emageneti ayo anobatsira vanachiremba kunzvenga kupinza uye kuisa njodzi yemongo wemapfupa.

Matambudziko akapoteredza chirwere ichi anogona kurondwa kumashure anopfuura makore makumi matatu apfuura, apo oncologist Kevin Shannon, MD, weYunivhesiti yeCalifornia, San Francisco, uye vaaishanda navo vakasangana nemhuri dzinoverengeka, dzakawanda dzadzo dzinogona kunge dziine masero eropa mashoma (abnormal myelodysplastic). Syndrome) Chiratidzo kana MDS) uye acute myeloid leukemia (AML), gomarara reropa rakaipisisa uye rinouraya. Varwere ava vane imwe panzvimbo yemakopi maviri echromosome 30, inonzi single chromosome 7.

The data shows that mutations in the genes SAMD9 and SAMD9L located on chromosome 7 are closely related to single chromosome 7 syndrome, but many healthy siblings and patients’ parents also carry these mutations without any symptoms. Researchers have shown that patients who do have symptoms of MDS and AML also have a specific secondary gene mutation, which can drive a more serious disease, and patients without these additional mutations often never experience any symptoms and may develop blood. The count is low but most can recover on their own without treatment.

Kuchinja kwemajini pakromozomu 7 kunowanzoitika muvarwere vane AML neMDS, uye mapundu akaipa ekromozomu imwe chete 7 anobatanidzwa nekusaziva fungidziro uye haapindure zvakanaka kumishonga iripo. Neanopfuura mazana masere nemakumi matanhatu emajini pachromosome 860, zvichave zvinonakidza kunzwisisa basa reSAMD7 neSAMD9L mune isiri-yemhuri MDS neAML uye mabatiro avanoita nemamwe majini pakromosome 99.

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa
CAR T-Cell kurapa

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa

Cytokine Release Syndrome (CRS) is immune system reaction inowanzo kukonzerwa nemamwe marapirwo senge immunotherapy kana CAR-T cell therapy. Zvinosanganisira kuburitswa kwakanyanya kwemacytokines, zvichikonzera zviratidzo kubva pafivha uye kuneta kusvika kune zvinogona kuuraya hupenyu sekukuvadzwa kwenhengo. Kutungamira kunoda kunyatsotarisisa uye nzira dzekupindira.

Basa revaparamedics mukubudirira kweCAR T Cell therapy
CAR T-Cell kurapa

Basa revaparamedics mukubudirira kweCAR T Cell therapy

Paramedics inobata basa rakakosha mukubudirira kweCAR T-cell therapy nekuona kuchengetwa kwemurwere pasina musono panguva yese yekurapa. Vanopa rubatsiro rwakakosha panguva yekufambisa, kutarisa zviratidzo zvinokosha zvevarwere, uye kupa rubatsiro rwechimbichimbi kana matambudziko amuka. Kupindura kwavo nekukurumidza uye kutarisirwa kwehunyanzvi kunobatsira mukuchengetedzeka kwese uye kushanda kwekurapa, kufambisa shanduko yakapfava pakati pezvirongwa zvehutano uye kuvandudza mhedzisiro yevarwere munzvimbo yakaoma yemhando yepamusoro cellular therapies.

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa